Caplin continues doing well, with sales growing by 16% and EPS by 20%. Caplin steriles is now generating 26% EBITDA margins. Concall notes below.
FY25Q1
-
LATAM
-
Open a warehouse in capital of Chile with registration for 70-72 products. 70% government + 30% private market business
-
Started warehouse in Guatemala
-
Mexico: 8-9 registrations. Will launch warehouse and front end sales when they reach 25-30 registrations
-
Started branded generic business in Guatemala, El Salvador and Honduras.
-
Focusing more on registration in Mexico and Chile
-
-
Caplin One factor will enjoy 8% taxes
-
US/Caplin sterile:
-
Contribution increased to 16% (vs 11% last year), 70% growth
-
73 cr. sales, 19.3 cr. EBITDA
-
75:25 product revenue:milestone resulted in higher gross margins of 73%. 100% gross margins on milestone resulted in higher gross margins
-
Caplin Steriles label will be launched by October or November 2024 with 30+ product launches in first 12 to 15 months
-
Will be targeting smaller warehouses and IDMs rather than big 3
-
Filed 3 ANDAs (costed 6 cr.)
-
Confident of reaching $100mn sales by FY27
-
-
Phase III of Caplin Steriles capex for injectable division will be done under Caplin One Labs and cater to US. Expecting 220-240 cr. investments over 2 to 3 years
-
70-80% logbooks are converted to digital
-
Standalone business metrics not relevant because they acquired distribution partners over past 5-6 years through subsidiaries + Caplin Steriles is not part of standalone
-
General category API plant at Vizag should start trials by end of year. 15-18 months away from filing own DMFs. Focusing more on formulations and marketing than backward integration. Have incurred 40 cr. capex, 20 cr. capex required for general API plant + 60-70 cr. for oncology API plant
-
Cash build up, looking for acquisitions: A) brand marketing, B) distribution company with a good network of supplying to various institutions and pharmacies catering to the bottom of the pyramid, C) brand and ANDA acquisitions
Disclosure: Invested (no transactions in last-30 days)